arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

AVITA Medical, Inc.

RCEL
$15.72 ▼ -0.58 (-3.56%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
33 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
55
Health
Fair
Neutral
auto_awesome

Analytical Summary

AVITA Medical, Inc. shows mixed fundamentals. However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $483.4M
Dividend Yield —
Revenue Growth 17.8% ↗
Op. Margin -31.6% ↗
ROIC 24.7% ↘
FCF / Share $-0.12 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

33-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$21.70M
↑ +17.8% —
Net Income Profit after all expenses
$-7.66M
↑ +22.8% —
Operating Margin Operating profit as % of sales
-31.6%
↑ +30.9% 4th
FCF / Share Free cash flow per share
$-0.12
↑ +64.5% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
5
Returns
100
Financial Health ↑
64
Cash Quality ↓
47

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 33 quarters